ホーム › 前立腺がん › オハイオ › Cincinnati
Cincinnati、OHにおける前立腺がんの臨床試験
Cincinnatiとその周辺地域（約30マイル以内）の拠点で、前立腺がんに関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- 他3件
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
被験者募集中第2相
- Saint Elizabeth Healthcare Edgewood, Edgewood · 8マイル先
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
被験者募集中第3相
- TriState Urologic Services PSC Inc. dba The Urology Group, Cincinnati
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
被験者募集中第3相
- Oncology Hematology Care Incorporated, Cincinnati
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
被験者募集中第3相
- Urology Group - Solaris Network, Cincinnati
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
被験者募集中第1相
- Oncology Hematology Care Incorporated, Cincinnati
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
被験者募集中第2相
- Solaris Health - The Urology Group, Cincinnati
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
被験者募集中第1相
- Oncology Hematology Care Incorporated, Cincinnati
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
被験者募集中第3相
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
被験者募集中第1相
- University of Cincinnati Medical Center, Cincinnati
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
被験者募集中第3相
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- 他1件
Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)
被験者募集中観察研究
- The University of Cinncinatti, Cincinnati
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
被験者募集中第2相
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- 他1件
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
被験者募集中第3相
- Oncology Hematology Care Inc-Kenwood, Cincinnati
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
被験者募集中第1/2相
- Research Site 113, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Cincinnati
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
被験者募集中第3相
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15マイル先
Real World Prostate Cancer Registry
被験者募集中観察研究
- Cincinnati Cancer Advisors, Cincinnati
他の都市における前立腺がんの試験
- New York City, NY103件の研究
- Houston, TX76件の研究
- Los Angeles, CA61件の研究
- Boston, MA59件の研究
- St. Louis, MO46件の研究
- Chicago, IL45件の研究
- San Francisco, CA45件の研究
- Philadelphia, PA44件の研究
- Baltimore, MD43件の研究
- Nashville, TN42件の研究
- Seattle, WA42件の研究
- Washington, DC38件の研究
Cincinnatiにおける他の研究
- 非小細胞肺癌35件の研究
- がん（全種類）27件の研究
- 乳がん25件の研究
- 心不全24件の研究
- 大腸癌21件の研究
- 急性骨髄性白血病20件の研究
- 転移性癌20件の研究
- 卵巣がん19件の研究
- 肺がん19件の研究
- 肥満症19件の研究
- 多発性骨髄腫17件の研究
- 悪性黒色腫17件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。